TGFB1 and Myocardial fibrosis: To elucidate the relationship between SP and the TGF-β1/Smads signaling pathway in the development of myocardial fibrosis of DCM, in this study, SP and an inhibitor of this signaling pathway (LY2109761) were added to HG-treated CFs.